Table 1.
GBM-derived EV cargoes and their functional impacts.
Recipient cells | Cargo | Biological effects | |
---|---|---|---|
Intra-Tumoral | Tumor cells | mtDNA | nd18 |
miR-1 | Tumorgenicity, invasion and growth34 | ||
miR-21 | Anti-apoptosis, proliferation10,17 | ||
hypoxia signatureEGFRvIIIclic1proteinsTrkB | Cell migration14Tumor growth12Tumor growth65GBM subtype tumorigenesis25Aggressiveness50 | ||
Endothelial cells | miR-9mRNAshypoxia signatureangiogenic factorssemaphorin 3A | Migration, angiogenesis66Angiogenesis10Angiogenesis14Angiogenesis10Permeability21 | |
Microglia Monocyte/macrophage | miR-451, miR-21 | Cytokine profile32 | |
Extra-Tumoral | Endothelial cells | Pro-coagulation39, 40 | |
Endothelial cells Monocyte/macrophage | semaphorin 3A | nd21 | |
TrkB | nd50 | ||
proteins | M2 phenotype37 | ||
Lymphocyte | proteins | Immunotolerance67 |
nd: not determined